Owen J. Sansom

51.4k total citations · 11 hit papers
311 papers, 23.8k citations indexed

About

Owen J. Sansom is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Owen J. Sansom has authored 311 papers receiving a total of 23.8k indexed citations (citations by other indexed papers that have themselves been cited), including 199 papers in Molecular Biology, 142 papers in Oncology and 57 papers in Cancer Research. Recurrent topics in Owen J. Sansom's work include Wnt/β-catenin signaling in development and cancer (57 papers), Cancer Cells and Metastasis (48 papers) and Genetic factors in colorectal cancer (39 papers). Owen J. Sansom is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (57 papers), Cancer Cells and Metastasis (48 papers) and Genetic factors in colorectal cancer (39 papers). Owen J. Sansom collaborates with scholars based in United Kingdom, United States and Netherlands. Owen J. Sansom's co-authors include Alan R. Clarke, Rachel A. Ridgway, Jennifer P. Morton, Hans Clevers, Nick Barker, Valerie G. Brunton, Dimitris Athineos, Marc van de Wetering, Harry Begthel and Johan H. van Es and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Owen J. Sansom

302 papers receiving 23.5k citations

Hit Papers

Crypt stem cells as the c... 2004 2026 2011 2018 2008 2009 2009 2004 2012 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Owen J. Sansom United Kingdom 80 14.4k 8.8k 4.9k 3.5k 2.8k 311 23.8k
Hong Wu United States 89 16.6k 1.2× 7.2k 0.8× 4.5k 0.9× 2.1k 0.6× 3.1k 1.1× 204 26.2k
Jian Yu United States 69 13.5k 0.9× 6.4k 0.7× 3.6k 0.7× 2.3k 0.7× 2.0k 0.7× 262 20.4k
Gerhard Christofori Switzerland 71 12.4k 0.9× 7.1k 0.8× 4.5k 0.9× 2.9k 0.8× 1.7k 0.6× 163 19.6k
Michael J. Birrer United States 83 13.5k 0.9× 9.5k 1.1× 5.1k 1.0× 1.5k 0.4× 3.2k 1.2× 434 25.4k
Lynda Chin United States 82 20.4k 1.4× 9.3k 1.0× 6.7k 1.4× 2.9k 0.8× 2.6k 0.9× 160 29.4k
Thomas Brabletz Germany 65 15.3k 1.1× 10.2k 1.2× 7.5k 1.5× 2.4k 0.7× 2.0k 0.7× 174 23.0k
Nabeel Bardeesy United States 84 19.1k 1.3× 12.0k 1.4× 7.4k 1.5× 3.7k 1.1× 2.8k 1.0× 182 30.8k
Lena Claesson‐Welsh Sweden 87 22.2k 1.5× 6.9k 0.8× 5.8k 1.2× 4.8k 1.4× 3.5k 1.3× 256 32.3k
Eduard Batlle Spain 48 11.7k 0.8× 9.4k 1.1× 3.7k 0.8× 2.3k 0.7× 2.8k 1.0× 87 19.8k
Eric W.‐F. Lam United Kingdom 87 15.3k 1.1× 5.4k 0.6× 4.0k 0.8× 1.7k 0.5× 3.5k 1.3× 298 23.1k

Countries citing papers authored by Owen J. Sansom

Since Specialization
Citations

This map shows the geographic impact of Owen J. Sansom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Owen J. Sansom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Owen J. Sansom more than expected).

Fields of papers citing papers by Owen J. Sansom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Owen J. Sansom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Owen J. Sansom. The network helps show where Owen J. Sansom may publish in the future.

Co-authorship network of co-authors of Owen J. Sansom

This figure shows the co-authorship network connecting the top 25 collaborators of Owen J. Sansom. A scholar is included among the top collaborators of Owen J. Sansom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Owen J. Sansom. Owen J. Sansom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Colin Y.C., Isaac Dean, Nathan Richoz, et al.. (2025). In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade. Cancer Immunology Research. 13(9). 1453–1470.
2.
Neerven, Sanne M. van, Nina E. de Groot, Karen-Sue Carlson, et al.. (2022). The extracellular matrix controls stem cell specification and crypt morphology in the developing and adult mouse gut. Biology Open. 11(12). 8 indexed citations
3.
Patel, Rachana, Catriona A. Ford, Lisa Rodgers, et al.. (2022). Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression. Cancer Research. 82(14). 2565–2575. 20 indexed citations
4.
Swaminathan, Karthic, Andrew D. Campbell, Vassilis Papalazarou, et al.. (2020). The RAC1 Target NCKAP1 Plays a Crucial Role in the Progression of Braf;Pten-Driven Melanoma in Mice. Journal of Investigative Dermatology. 141(3). 628–637.e15. 12 indexed citations
5.
Loveridge, Carolyn J., Ernest Mui, Rachana Patel, et al.. (2017). Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten -Deficient Mouse Model of Prostate Carcinogenesis. Cancer Research. 77(12). 3158–3168. 15 indexed citations
6.
D’Costa, Zenobia, Keaton Jones, Abul Kalam Azad, et al.. (2017). Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer. Cancer Research. 77(21). 5952–5962. 51 indexed citations
7.
Spender, Lindsay C., Gail Ferguson, Sijia Liu, et al.. (2016). Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells. Oncotarget. 7(50). 81995–82012. 18 indexed citations
8.
Driscoll, David R., Saadia A. Karim, Makoto Sano, et al.. (2016). mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer. Cancer Research. 76(23). 6911–6923. 58 indexed citations
9.
Wiegering, Armin, Thomas Jamieson, Melanie Hüttenrauch, et al.. (2015). Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer. Cancer Discovery. 5(7). 768–781. 84 indexed citations
10.
Ueberham, Elke, Beate K. Straub, Daniel Teupser, et al.. (2014). Global Increase of p16INK4a in APC-Deficient Mouse Liver Drives Clonal Growth of p16INK4a-Negative Tumors. Molecular Cancer Research. 13(2). 239–249. 5 indexed citations
11.
Bird, Thomas G., Wei‐Yu Lu, Luke Boulter, et al.. (2013). Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proceedings of the National Academy of Sciences. 110(16). 6542–6547. 132 indexed citations
12.
Nobis, Max, Ewan J. McGhee, Jennifer P. Morton, et al.. (2013). Intravital FLIM-FRET Imaging Reveals Dasatinib-Induced Spatial Control of Src in Pancreatic Cancer. Cancer Research. 73(15). 4674–4686. 99 indexed citations
13.
Laine, Anni, Harri Sihto, Christophé Côme, et al.. (2013). Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1. Cancer Discovery. 3(2). 182–197. 101 indexed citations
14.
Guest, Rachel V., Luke Boulter, Timothy J. Kendall, et al.. (2013). Cell Lineage Tracing Reveals a Biliary Origin of Intrahepatic Cholangiocarcinoma. Cancer Research. 74(4). 1005–1010. 90 indexed citations
15.
Cordero, Julia B., Rhoda Stefanatos, Alessandro Scopelliti, Marcos Vidal, & Owen J. Sansom. (2012). Inducible progenitor-derived Wingless regulates adult midgut regeneration in Drosophila. The EMBO Journal. 31(19). 3901–3917. 115 indexed citations
16.
Timpson, Paul, Ewan J. McGhee, Jennifer P. Morton, et al.. (2011). Spatial Regulation of RhoA Activity during Pancreatic Cancer Cell Invasion Driven by Mutant p53. Cancer Research. 71(3). 747–757. 109 indexed citations
17.
Jamieson, Nigel B., Jennifer P. Morton, Asif Ali, et al.. (2011). MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 18(2). 534–545. 175 indexed citations
18.
Cole, Alicia M., Kevin Myant, Karen R. Reed, et al.. (2010). Cyclin D2–Cyclin-Dependent Kinase 4/6 Is Required for Efficient Proliferation and Tumorigenesis following Apc Loss. Cancer Research. 70(20). 8149–8158. 65 indexed citations
19.
Morton, Jennifer P., Paul Timpson, Saadia A. Karim, et al.. (2009). Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proceedings of the National Academy of Sciences. 107(1). 246–251. 465 indexed citations
20.
Méniel, Valérie S., Trevor Hay, Anthony Douglas-Jones, Owen J. Sansom, & Alan R. Clarke. (2005). Mutations in Apc and p53 Synergize to Promote Mammary Neoplasia. Cancer Research. 65(2). 410–416. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026